These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19591190)

  • 21. Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of action.
    Bartolini M; Bertucci C; Bolognesi ML; Cavalli A; Melchiorre C; Andrisano V
    Chembiochem; 2007 Nov; 8(17):2152-61. PubMed ID: 17939148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-amyloid-derived pentapeptide RIIGLa inhibits Abeta(1-42) aggregation and toxicity.
    Fülöp L; Zarándi M; Datki Z; Soós K; Penke B
    Biochem Biophys Res Commun; 2004 Nov; 324(1):64-9. PubMed ID: 15464983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interface peptide of Alzheimer's amyloid beta: application in purification.
    Das U; Hariprasad G; Pasha S; Mann A; Ganguli M; Sharma S; Kaur P; Singh TP; Srinivasan A
    Biochem Biophys Res Commun; 2007 Oct; 362(2):538-42. PubMed ID: 17707778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion.
    Peretto I; Radaelli S; Parini C; Zandi M; Raveglia LF; Dondio G; Fontanella L; Misiano P; Bigogno C; Rizzi A; Riccardi B; Biscaioli M; Marchetti S; Puccini P; Catinella S; Rondelli I; Cenacchi V; Bolzoni PT; Caruso P; Villetti G; Facchinetti F; Del Giudice E; Moretto N; Imbimbo BP
    J Med Chem; 2005 Sep; 48(18):5705-20. PubMed ID: 16134939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing Alzheimer amyloid peptide aggregation using a cell-free fluorescent protein refolding method.
    Arslan PE; Chakrabartty A
    Biochem Cell Biol; 2009 Aug; 87(4):631-9. PubMed ID: 19767826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The geminal dimethyl analogue of Flurbiprofen as a novel Abeta42 inhibitor and potential Alzheimer's disease modifying agent.
    Stock N; Munoz B; Wrigley JD; Shearman MS; Beher D; Peachey J; Williamson TL; Bain G; Chen W; Jiang X; St-Jacques R; Prasit P
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2219-23. PubMed ID: 16455248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA aptamers selected against amyloid beta-peptide (Abeta) inhibit the aggregation of Abeta.
    Takahashi T; Tada K; Mihara H
    Mol Biosyst; 2009 Sep; 5(9):986-91. PubMed ID: 19668864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of beta-amyloid peptide aggregation and neurotoxicity by alpha-d-mannosylglycerate, a natural extremolyte.
    Ryu J; Kanapathipillai M; Lentzen G; Park CB
    Peptides; 2008 Apr; 29(4):578-84. PubMed ID: 18304694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential lead for an Alzheimer drug: a peptide that blocks intermolecular interaction and amyloid beta protein-induced cytotoxicity.
    Kwak JW; Kim HK; Chae CB
    J Med Chem; 2006 Aug; 49(16):4813-7. PubMed ID: 16884292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of recombinant amyloid-beta peptide 42 as an ubiquitin extension.
    Lee EK; Hwang JH; Shin DY; Kim DI; Yoo YJ
    Protein Expr Purif; 2005 Mar; 40(1):183-9. PubMed ID: 15721787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diverse ecdysterones show different effects on amyloid-β42 aggregation but all uniformly inhibit amyloid-β42-induced cytotoxicity.
    Yang SG; Zhang X; Sun XS; Ling TJ; Feng Y; Du XY; Zhao M; Yang Y; Xue D; Wang L; Liu RT
    J Alzheimers Dis; 2010; 22(1):107-17. PubMed ID: 20847437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytosolic amyloid-beta peptide 42 escaping from degradation induces cell death.
    Lee EK; Park YW; Shin DY; Mook-Jung I; Yoo YJ
    Biochem Biophys Res Commun; 2006 Jun; 344(2):471-7. PubMed ID: 16630565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.
    Fernández-Bachiller MI; Pérez C; Campillo NE; Páez JA; González-Muñoz GC; Usán P; García-Palomero E; López MG; Villarroya M; García AG; Martínez A; Rodríguez-Franco MI
    ChemMedChem; 2009 May; 4(5):828-41. PubMed ID: 19308922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro ADMET and physicochemical investigations of poly-N-methylated peptides designed to inhibit Abeta aggregation.
    Bose PP; Chatterjee U; Hubatsch I; Artursson P; Govender T; Kruger HG; Bergh M; Johansson J; Arvidsson PI
    Bioorg Med Chem; 2010 Aug; 18(16):5896-902. PubMed ID: 20659803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro effects of SIKVAV retro and retro-enantio analogues on tumor metastatic events.
    Almiñana N; Grau-Oliete MR; Reig F; Rivera-Fillat MP
    Peptides; 2004 Feb; 25(2):251-9. PubMed ID: 15063006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human apolipoprotein A-I binds amyloid-beta and prevents Abeta-induced neurotoxicity.
    Paula-Lima AC; Tricerri MA; Brito-Moreira J; Bomfim TR; Oliveira FF; Magdesian MH; Grinberg LT; Panizzutti R; Ferreira ST
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1361-70. PubMed ID: 19130896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A high-throughput screen for compounds that inhibit aggregation of the Alzheimer's peptide.
    Kim W; Kim Y; Min J; Kim DJ; Chang YT; Hecht MH
    ACS Chem Biol; 2006 Aug; 1(7):461-9. PubMed ID: 17168524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of LVFFARK and LVFFARK-functionalized nanoparticles for inhibiting amyloid β-protein fibrillation and cytotoxicity.
    Xiong N; Dong XY; Zheng J; Liu FF; Sun Y
    ACS Appl Mater Interfaces; 2015 Mar; 7(10):5650-62. PubMed ID: 25700145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and biological evaluation of glycine-based molecular tongs as inhibitors of Abeta1-40 aggregation in vitro.
    Cellamare S; Stefanachi A; Stolfa DA; Basile T; Catto M; Campagna F; Sotelo E; Acquafredda P; Carotti A
    Bioorg Med Chem; 2008 May; 16(9):4810-22. PubMed ID: 18406152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybrid peptides attenuate cytotoxicity of beta-amyloid by inhibiting its oligomerization: implication from solvent effects.
    Sun X; Wu WH; Liu Q; Chen MS; Yu YP; Ma Y; Zhao YF; Li YM
    Peptides; 2009 Jul; 30(7):1282-7. PubMed ID: 19397942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.